Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

METHIMAZOLE

METHIMAZOLE

Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview METHIMAZOLE is listed in Drugs@FDA under application 040619 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METHIMAZOLE Form and strength TABLET;ORAL - 15MG Sponsor DISCOVERY THERAP Submission history Latest submission status date: 2019-01-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview METHIMAZOLE is listed in Drugs@FDA under application 040619 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHIMAZOLE Form and strength TABLET;ORAL - 15MG Sponsor DISCOVERY THERAP Submission history Latest submission status date: 2019-01-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.